Said Gary Buehler.

The battle for life with high quality anti-retroviral treatment to rescue FDA of considerable importance, said Gary Buehler, director of the FDA’s Office of Generic Drugs. Our scientists have worked diligently to ensure safe and effective treatments for AIDS available as quickly as possible, this global problem make. .

The action marks the first tentative approval for a nucleotide analog reverse transcriptase inhibitor . NRTI block an enzyme called reverse transcriptase , which is important for HIV – production.– 700,000 people in the UK have form of dementia, more than half of have AD. In under 20 years close to a million people suffering from dementia lives. It will continue to increase to 1.7 million people in 2051.